Calunod, Jhon Kyven A.

HRN: 22-73-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/08/2025
07/16/2025
PO
10ml
TID
Peritonsillar Abscess
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & MouthProphylaxis    Compliance to guidelines: